RANBP3 and neoplasm: Furthermore, the tumor xenografts established by RanBP3‐deficient DLD1‐sgRanBP3 and HCT15‐sgRanBP3 cells were significantly larger than those established by the control cells, with decreases in size of 62.8% and 66.2%, respectively.